Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from INVITED PERSPECTIVES

  • You have access
    Could FAP-targeted molecular imaging replace FDG for standard-of-care oncologic PET?
    Raghava Kashyap and Aravind S Ravi Kumar
    Journal of Nuclear Medicine February 2, 2023, jnumed.122.265003; DOI: https://doi.org/10.2967/jnumed.122.265003
  • You have access
    Extravasation of diagnostic radiopharmaceuticals, a wolf in sheep's clothing?
    Jochem A. J. van der Pol and Felix Manuel Mottaghy
    Journal of Nuclear Medicine December 15, 2022, jnumed.122.265038; DOI: https://doi.org/10.2967/jnumed.122.265038
  • You have access
    Tau PET Visual Reads: Research and Clinical Applications and Future Directions
    David N. Soleimani-Meigooni and Gil D. Rabinovici
    Journal of Nuclear Medicine December 8, 2022, jnumed.122.265017; DOI: https://doi.org/10.2967/jnumed.122.265017
  • You have access
    Radiomics in PET/CT: More Than Meets the Eye?
    Mathieu Hatt, Florent Tixier, Dimitris Visvikis and Catherine Cheze Le Rest
    Journal of Nuclear Medicine March 1, 2017, 58 (3) 365-366; DOI: https://doi.org/10.2967/jnumed.116.184655
  • You have access
    Metabolic Tumor Volume: We Still Need a Platinum-Standard Metric
    Andrea Gallamini and Lale Kostakoglu
    Journal of Nuclear Medicine February 1, 2017, 58 (2) 196-197; DOI: https://doi.org/10.2967/jnumed.116.184663
  • You have access
    Citius, Altius, Fortius: An Olympian Dream for Theranostics
    Rodney J. Hicks
    Journal of Nuclear Medicine February 1, 2017, 58 (2) 194-195; DOI: https://doi.org/10.2967/jnumed.116.182188
  • You have access
    From NETTER to PETTER: PSMA-Targeted Radioligand Therapy
    Matthias Eiber and Ken Herrmann
    Journal of Nuclear Medicine January 1, 2017, 58 (1) 9-10; DOI: https://doi.org/10.2967/jnumed.116.184994
  • You have access
    The Controversial Linear No-Threshold Model
    Wolfgang Weber and Pat Zanzonico
    Journal of Nuclear Medicine January 1, 2017, 58 (1) 7-8; DOI: https://doi.org/10.2967/jnumed.116.182667
  • You have access
    Quantitative Radionuclide Assessment of Cardiac Dyssynchrony: Breakthrough in Patient Selection for Cardiac Resynchronization Therapy for Refractory Heart Failure?
    Erica O. Miller, Saurabh Malhotra and Ronald G. Schwartz
    Journal of Nuclear Medicine December 1, 2016, 57 (12) 1840-1842; DOI: https://doi.org/10.2967/jnumed.116.177113
  • You have access
    Targeted α-Based Treatment of Metastatic Castration-Resistant Prostate Cancer: Revolutionizing Systemic Radiotherapy?
    Wim J.G. Oyen and Johann S. de Bono
    Journal of Nuclear Medicine December 1, 2016, 57 (12) 1838-1839; DOI: https://doi.org/10.2967/jnumed.116.179887

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 14
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire